GENERIUM sell "Elizaria® (eculizumab)"
Basic Information
685
24
14
4.1(74)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Elizaria® (eculizumab)
Specifications
- Application: Complement C5 inhibitor monoclonal antibody biosimilar, indicated for paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)
- Formulation Type: Biosimilar monoclonal antibody formulation of eculizumab
- Regulatory Status: Developed and positioned as a biosimilar to the reference eculizumab product
Other Information
Additional Description:
Indicated for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment